Rapamycin treatment for a child with germline PTEN mutation
Nature Clinical Practice Oncology · 2008-06 · 5 (6) · 357-361
DOI: 10.1038/ncponc1112 ↗Kurz gefasst
Fallbericht in der Zeitschrift Nature Clinical Practice Oncology, online erschienen am 22.04.2008. Verfasst von Deborah J Marsh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Kolling Institute of Medical Research, University of Sydney and Royal North Shore Hospital, Sydney, NSW, Australia. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Kolling Institute of Medical Research, University of Sydney and Royal North Shore Hospital, Sydney, NSW, Australia.
Zitieren
APA
Marsh, D. J., Trahair, T. N., Martin, J. L., Chee, W. Y., Walker, J., Kirk, E. P., Baxter, R. C., & Marshall, G. M. (2008). Rapamycin treatment for a child with germline PTEN mutation. Nature Clinical Practice Oncology, 5(6), 357-361. https://doi.org/10.1038/ncponc1112
Vancouver
Marsh DJ, Trahair TN, Martin JL, Chee WY, Walker J, Kirk EP, et al. Rapamycin treatment for a child with germline PTEN mutation. Nature Clinical Practice Oncology. 2008;5(6):357-361. doi:10.1038/ncponc1112
BibTeX
@article{Marsh2008,
author = {Marsh, Deborah J and Trahair, Toby N and Martin, Janet L and Chee, Wey Yeeng and Walker, Jan and Kirk, Edwin P and Baxter, Robert C and Marshall, Glenn M},
title = {Rapamycin treatment for a child with germline PTEN mutation},
journal = {Nature Clinical Practice Oncology},
year = {2008},
volume = {5},
number = {6},
pages = {357--361},
doi = {10.1038/ncponc1112}
}
EUVIMED